Atipamezole

Revision as of 14:42, 10 April 2015 by Kiran Singh (talk | contribs)
Jump to navigation Jump to search
Atipamezole
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Legal status
Legal status
  • Veterinary use only
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H16N2
Molar mass212.290 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Atipamezole

Articles

Most recent articles on Atipamezole

Most cited articles on Atipamezole

Review articles on Atipamezole

Articles on Atipamezole in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atipamezole

Images of Atipamezole

Photos of Atipamezole

Podcasts & MP3s on Atipamezole

Videos on Atipamezole

Evidence Based Medicine

Cochrane Collaboration on Atipamezole

Bandolier on Atipamezole

TRIP on Atipamezole

Clinical Trials

Ongoing Trials on Atipamezole at Clinical Trials.gov

Trial results on Atipamezole

Clinical Trials on Atipamezole at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atipamezole

NICE Guidance on Atipamezole

NHS PRODIGY Guidance

FDA on Atipamezole

CDC on Atipamezole

Books

Books on Atipamezole

News

Atipamezole in the news

Be alerted to news on Atipamezole

News trends on Atipamezole

Commentary

Blogs on Atipamezole

Definitions

Definitions of Atipamezole

Patient Resources / Community

Patient resources on Atipamezole

Discussion groups on Atipamezole

Patient Handouts on Atipamezole

Directions to Hospitals Treating Atipamezole

Risk calculators and risk factors for Atipamezole

Healthcare Provider Resources

Symptoms of Atipamezole

Causes & Risk Factors for Atipamezole

Diagnostic studies for Atipamezole

Treatment of Atipamezole

Continuing Medical Education (CME)

CME Programs on Atipamezole

International

Atipamezole en Espanol

Atipamezole en Francais

Business

Atipamezole in the Marketplace

Patents on Atipamezole

Experimental / Informatics

List of terms related to Atipamezole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Atipamezole (brand name Antisedan, Pfizer) is a synthetic α2 adrenergic receptor antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1] It has also been researched in humans as a potential anti-Parkinsonian drug.[2]

See also

References

  1. Pfizer Animal Health ANTISEDAN Product Overview
  2. Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews. 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.

External links